Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

T2R50 Inhibitors

T2R50, part of the bitter taste receptor family T2Rs, is a G-protein coupled receptor (GPCR) implicated in the perception of bitterness. These receptors are expressed predominantly on the surface of taste receptor cells located within the taste buds of the tongue and are responsible for sending signals to the brain when a bitter compound is detected. T2R50, like other T2Rs, is encoded by a specific gene. The expression of this gene-and consequently, the presence of the T2R50 protein-can be regulated by a variety of molecular mechanisms, including the transcription factors that bind to its promoter region, the epigenetic modifications that can make its gene more or less accessible, and the intracellular signaling pathways that can increase or decrease the transcription of the gene. Certain chemicals have the potential to inhibit the expression of T2R50 by interacting with these regulatory mechanisms. For example, compounds that alter the epigenetic landscape, such as DNA methyltransferase inhibitors or histone deacetylase inhibitors, could downregulate T2R50 expression by changing the methylation status of its gene or modifying histone acetylation, respectively. Other chemicals may interact with signaling pathways that influence T2R50 gene transcription. For instance, inhibitors of the PI3K/AKT pathway, the MAPK/ERK pathway, or the JNK pathway might reduce T2R50 expression by hindering the pathways that normally lead to its activation. Moreover, substances that affect the cellular stress response, such as antioxidants, could also play a role in the downregulation of T2R50 by altering the cellular environment and the regulatory networks that control gene expression. It is important to note that while these interactions are plausible based on the compounds' known mechanisms of action, specific research is necessary to confirm any actual effects on T2R50 expression. The interplay between these chemicals and the T2R50 receptor is an area ripe for exploration to better understand the nuanced regulation of taste receptor gene expression.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

This compound could hypothetically reduce T2R50 expression by inducing hypomethylation of its gene promoter, leading to a suppressed transcription within taste buds.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Trichostatin A may downregulate T2R50 by remodeling chromatin structure around its encoding gene, resulting in decreased accessibility for transcription machinery.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin may decrease T2R50 protein levels indirectly by impeding mTOR signaling, which is crucial for various cellular processes including protein synthesis.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

By inhibiting PI3K, LY294002 could lead to a decrease in AKT signaling, which may result in lower transcriptional activation of genes like T2R50.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD 98059 could lead to a reduction in ERK pathway signaling, potentially resulting in a downregulated expression of T2R50 due to lessened transcriptional activity.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

Inhibiting p38 MAPK with SB 203580 could lead to decreased response to cellular stressors, which may include a reduction in the expression of genes like T2R50.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125's inhibition of JNK could lead to a downstream decrease in AP-1 activity, which in turn may result in the downregulation of T2R50 expression.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

U0126 may inhibit the MEK pathway, potentially leading to reduced MAPK/ERK pathway signaling and consequently lower levels of T2R50 expression.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$37.00
$69.00
$109.00
$218.00
$239.00
$879.00
$1968.00
47
(1)

Curcumin may downregulate T2R50 by altering the transcriptional activity within the promoter region of the gene, leading to diminished expression.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

Resveratrol could decrease the expression of T2R50 by altering the activity of sirtuins and other transcription factors involved in the cellular stress response pathways.